RNA splicing and splicing regulator changes in prostate cancer pathology
Author:
Funder
Prostate Cancer UK
Publisher
Springer Science and Business Media LLC
Subject
Genetics (clinical),Genetics
Link
http://link.springer.com/article/10.1007/s00439-017-1792-9/fulltext.html
Reference77 articles.
1. Aartsma-Rus A, Krieg AM (2017) FDA approves eteplirsen for Duchenne muscular dystrophy: the next chapter in the Eteplirsen Saga. Nucleic Acid Ther 27:1–3. doi: 10.1089/nat.2016.0657
2. Adamo P, Ladomery MR (2016) The oncogene ERG: a key factor in prostate cancer. Oncogene 35:403–414. doi: 10.1038/onc.2015.109
3. Allemand E, Myers MP, Garcia-Bernardo J, Harel-Bellan A, Krainer AR, Muchardt C (2016) A broad set of chromatin factors influences splicing. PLoS Genet 12:e1006318. doi: 10.1371/journal.pgen.1006318
4. Amin EM, Oltean S, Hua J, Gammons MV, Hamdollah-Zadeh M, Welsh GI, Cheung MK, Ni L, Kase S, Rennel ES, Symonds KE, Nowak DG, Royer-Pokora B, Saleem MA, Hagiwara M, Schumacher VA, Harper SJ, Hinton DR, Bates DO, Ladomery MR (2011) WT1 mutants reveal SRPK1 to be a downstream angiogenesis target by altering VEGF splicing. Cancer Cell 20:768–780. doi: 10.1016/j.ccr.2011.10.016
5. Anand AU, Bjartell A (2015) Re: AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer. Eur Urol 67:349–350. doi: 10.1016/j.eururo.2014.11.020
Cited by 46 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Alternative splicing and related RNA binding proteins in human health and disease;Signal Transduction and Targeted Therapy;2024-02-02
2. Epithelial specific splicing regulator proteins as emerging oncogenes in aggressive prostate cancer;Oncogene;2023-09-26
3. Nuclear Estrogen Receptors in Prostate Cancer: From Genes to Function;Cancers;2023-09-20
4. A Splicing Transcriptome-Wide Association Study Identifies Candidate Altered Splicing for Prostate Cancer Risk;OMICS: A Journal of Integrative Biology;2023-08-01
5. A role for androgen receptor variant 7 in sensitivity to therapy: Involvement of IGFBP-2 and FOXA1;Translational Oncology;2023-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3